We happily announce that Sensible Healthcare Systems, a Dutch company developing next generation continuous biosensors, has closed their pre-seed funding round in participation with Graduate Entrepreneur Fund and Glass Frog Ventures Group. The funds will be used to further develop and place on the market Sensible's minimally invasive continuous biosensing platform, initially focusing on the diabetes care market with a Continuous Glucose Monitoring (CGM) sensor.

‍

Diabetes is a chronic disease that affects millions of people worldwide, causing a significant physical and financial burden on patients. The increasing prevalence of diabetes also poses a significant public health challenge, highlighting the urgent need for effective management, preventive and curative strategies.

‍

Sensible Healthcare Systems is addressing this issue by developing the next generation of continuous biosensors that are not only cost-effective but also maintain top-of-market accuracy through a single-microneedle design that is over 40 times smaller than current sensors. These sensors operate with an open data architecture. This exclusive technology has the potential to enable a broader application of CGM sensors and ultimately enhance the lives of diabetes patients. The potential impact of this technology on population-scale diabetes management is significant, and it represents a promising advancement for the healthcare industry.

‍

About Sensible Healthcare Systems

Federico, Mart, and Tim, the founders of Sensible have stated the following: We couldn't be happier with the expertise and involvement that this group of investors has already shown, and are looking forward to work with them to expedite our endeavor to make valuable continuous insight into one's own biology accessible for all worldwide.

‍

Sensible Healthcare Systems was founded in 2019 by a team of professionals with diverse backgrounds, including researchers, engineering experts, and entrepreneurs. They started the company with a vision that current and even upcoming continuous glucose monitoring sensors have several flaws that make them unsuitable for widespread use, which is where their true potential lies. As Graduate Entrepreneur, we are very impressed to see what the team has accomplished up until now and we are very curious to see what the future holds!

‍

Learn more about Sensible on their website: https://sensible.health.

‍

‍